Iressa en es it fr

Iressa Brand names, Iressa Analogs

Iressa Brand Names Mixture

  • No information avaliable

Iressa Chemical_Formula


Iressa RX_link

Iressa fda sheet

Iressa FDA

Iressa msds (material safety sheet)

Iressa MSDS

Iressa Synthesis Reference

No information avaliable

Iressa Molecular Weight

446.902 g/mol

Iressa Melting Point

No information avaliable

Iressa H2O Solubility

Sparingly soluble (<pH4)

Iressa State


Iressa LogP


Iressa Dosage Forms


Iressa Indication

For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.

Iressa Pharmacology

Gefitinib inhibits the intracellular phosphorylation of numerous tyrosine kinases associated with transmembrane cell surface receptors, including the tyrosine kinases associated with the epidermal growth factor receptor (EGFR-TK). EGFR is expressed on the cell surface of many normal cells and cancer cells.

Iressa Absorption

Absorbed slowly after oral administration with mean bioavailability of 60%.

Iressa side effects and Toxicity

No information avaliable

Iressa Patient Information

Iressa Organisms Affected

Humans and other mammals